Natco Pharma Limited has informed the Exchange regarding Appointment of Mr T.C. Mallikarjun as Vice President - Quality Control of the company w.e.f. July 30, 2025.
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has appointed Mr. T.C. Mallikarjun as Vice President - Quality Control at its Pharma Division in Kothur, effective July 30, 2025. Mr. Mallikarjun brings experience from leading Indian pharmaceutical manufacturers, with prior exposure to regulatory inspections from agencies like USFDA, MHRA, TGA, and ANVISA. He was most recently associated with Aurobindo Pharma Limited, Hyderabad, where he served as Senior General Manager - Head QC. The appointment is part of the company's senior management team and follows the company's standard policy on terms of appointment.
This is a routine senior management appointment with no material impact on shareholders or stock price. The hire signals continued strengthening of Natco's quality and regulatory compliance capabilities, which is important for a pharma company serving global markets.